On the two slides you referenced (#33-34 from ENTA's latest slide set), I interpret the blank EC50 entries for other companies' HBV candidates to mean that ENTA does not have data available to enter a value. I.e., I do not interpret the blank entries to mean that the other companies' candidates lack activity in the cell line or HBV genotype in question.
If anyone disagrees with the above interpretation, or has other comments on mcbio's post, please reply!
Market Data 
Markets 
AI
